Join
Login
Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Orange Book Blog
Author's Profile
Author's Articles
Author's Website
Bookmark This Page
Author's Latest Articles
1
2
3
4
5
6
Page size:
select
10
20
50
107
items in
6
pages
"Defective" Complaint Triggers 30-Month Stay
Mar 14, 2013 01:22 PM |
ENDP
,
MYL
Novo Nordisk Requests FDA Advisory Opinion Concerning Orange Book Listing Of Patents On Pre-Filled Drug Delivery Devices
Feb 11, 2013 06:33 PM |
AZN
,
FRX
,
GSK
The America Invents Act: Basic Information for Patent Owners and Inventors
Nov 21, 2012 01:06 PM |
Third Circuit Issues Landmark Decision In Reverse Payment Case, Setting Up Supreme Court Review
Jul 18, 2012 12:30 PM |
CHQ
,
ESI
,
WPO
District Of Delaware: Paragraph IV Certification Not Required For Jurisdiction Under Section 271(E)(2) Or Declaratory Judgment Act
Mar 05, 2012 08:20 PM |
CEPH
Federal Circuit: Section Viii Statement Avoids Infringement Under § 271(E)(2)
Feb 10, 2012 12:20 PM |
AZN
Cephalon Ordered To Pay Anchen's Attorney Fees For Maintaining Suit Despite Having No Evidence Of Infringement
Jan 23, 2012 01:28 PM |
CEPH
Federal Circuit Vacates Preliminary Injunction Entered Against Mylan In Doxycycline Case
Dec 29, 2011 05:30 PM |
WCRX
Federal Circuit Affirms Invalidity Of Teva's Patent On Rosuvastatin Formulation
Dec 23, 2011 03:12 PM |
AZN
District Of Delaware Rules That API Manufacturer Cannot Be Sued Under Section 271(E)(2)
Nov 04, 2011 01:46 PM |
ASVI
,
CEPH
,
SLR
,
TEVA
,
WPI
ACI "Advanced Forum On Biotech Patents" Conference, Boston, Nov. 30 - Dec. 1
Oct 31, 2011 01:19 PM |
ACI
,
MCK
,
MSFT
Federal Circuit Confines 271(E)(1) Safe Harbor To Pre-Approval Activities
Sep 08, 2011 01:39 PM |
BIIB
,
GSK
,
MDT
,
MRK
Federal Trade Commission Issues Final Report On Authorized Generic Drugs
Sep 01, 2011 12:17 PM |
Federal Circuit Affirms Validity Of Argatroban Patent
Aug 09, 2011 07:02 PM |
Federal Circuit Confirms That Isolated DNA May Be Patented
Aug 02, 2011 11:09 AM |
MYGN
Federal Circuit Allows Par's Appeal Of ASACOL Declaratory Judgment Decision To Proceed
Jul 11, 2011 05:50 PM |
Federal Circuit Allows District Court Injunction Of Mylan's Generic AMRIX Sales To Stand
Jul 08, 2011 12:22 AM |
FDA Grants Baxter's Petition For Second 30-Month Stay Relating To Suprane
Jul 06, 2011 02:40 PM |
U.S. Supreme Court Confronts Inducement Of Infringement Under Section 271(B) For The First Time--What Does It Mean For ANDA Litigation?
Jun 13, 2011 12:33 AM |
En Banc Federal Circuit Reins In Inequitable Conduct
Jun 03, 2011 05:27 PM |
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.